[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$clls
$CLLS faces patent lawsuit, but R&D day and AstraZeneca partnership drive share movement. Biotech story gaining visibility, but execution and IP clearance remain focal.
About $clls
A cryptocurrency.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX +189%
6 Months: XXXXXXX +12,241%
1-Year High: XXXXXX on 2025-07-28
1-Year Low: X on 2025-09-08
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX +375%
6 Months: XXX +16,880%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-14
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $clls in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XXXX%
1 Month: XX +883%
6 Months: XXX +14,720%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-05-13
The most influential creators that mention $clls in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biobeats99 | X | XXX | X | X |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
1-Year High: XXX% on 2025-05-04
1-Year Low: XX% on 2025-08-25
Most Supportive Themes
- Strategic Collaboration & Pipeline Progress: (40%) Positive sentiment regarding Cellectis' strategic collaboration with AstraZeneca and advancements in gene therapy technologies.
- Positive Clinical Data: (30%) Enthusiasm for the promising Phase X results for lasme-cel in r/r B-ALL and the initiation of the pivotal Phase X BALLI-01 study.
Most Critical Themes
- Market Volatility & Patent Lawsuit: (20%) Concerns about price fluctuations and market uncertainty, along with the patent-infringement lawsuit filed by Factor and AstraZeneca.
- Dilution Concerns: (10%) Concerns about dilution due to a shelf offering.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XX | X% | ||
| Total | XX | X% | XX | X% | X | NaN% |
Top assets mentioned In the posts about $clls in the last XX hours
ATAI Life Sciences (ATAI) Coldstack (CLS) ATAI Life Sciences (ATAI) Nova Ltd. Ordinary Shares (NVMI) Dogechain (DC) Natera, Inc. Common Stock (NTRA) Hims & Hers Health, Inc. (HIMS) Hims & Hers Health, Inc. (HIMS) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) TransMedics Group, Inc. Common Stock (TMDX)
Top topics mentioned In the posts about $clls in the last XX hours
atai life, $ovid, $mnmd, $inbx, $asmb, stocks bitcoin treasuries, $cls, coins solana ecosystem, coins depin, coins storage, $atai, $trvi, $nvmi, $dc, coins meme, ab, $ntra, $phat, $hims, stocks consumer defensive, hims hers, $mirm, $tmdx, $rytm, $wgs, $xers, $tem, $pre, $onds, $stok, $tatt, $hovr, investment, $qure, $ktos, $avav, $odv
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Defense $ONDS $HOVR $AVAV $KTOS $TATT Biotech/Healthcare $QURE $STOK $OVID $PRE $TEM $XERS $WGS $CLLS $RYTM $TMDX $MIRM $HIMS $PHAT $NTRA"
X Link @equitydd 2025-10-26T00:46Z 4775 followers, XXX engagements
"$CLLS expanding with AstraZeneca but short-term challenges from clinical trials and lawsuits present risks. Focus on key levels: $XXXX support $XXXX resistance. Free real-time updatesjoin the group for live execution details"
X Link @santoso1934 2025-10-24T13:24Z XXX followers, XX engagements
"$CLLS trading near $3.47; clinical trial risks and legal concerns weigh heavily but long-term growth potential from strategic alliances with AstraZeneca could provide upside. Real-time signals are activefree access to updates inside"
X Link @Marigold1stock 2025-10-24T13:24Z XXX followers, XX engagements
"$CLLS falls -XXXX% to $3.47; volume 3.26M signals cautious sentiment. Strong strategic alliances with AstraZeneca and ongoing clinical trials could offer upside but near-term risks persist. Entry stop & targets updatedtrack the trade for free inside the group"
X Link @MiaCarterStock 2025-10-24T13:24Z XXX followers, XX engagements